Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report

doi:10.12998/wjcc.v10.i8.2537

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2868)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

295

WORD

104

HTML

1365

Figures (1-1)

210

Tables (1-1)

206

Sum=2180

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

232

Download

456

Sum=688

Mar 16, 2022 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Mar 16, 2022; 10(8): 2537-2542
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2537

Table 1 Laboratory values during hospitalization

Hospital day	Hb (g/L)	TT (s)	PT (s)	APTT (s)	INR	SCr (μmol/L)
Day 1	41	> 180	13.7	36.2	1.20	251
Day 2	67	N/A	N/A	N/A	N/A	N/A
Day 3	44	121.20	14.2	36.3	1.25	229
Day 4	56	17.40	13.1	25.9	1.15	213
Day 5	57	18	12.6	26.0	1.10	202
Day 6	76	N/A	N/A	N/A	N/A	182
Day 8	78	20.90	12.0	28.0	1.04	N/A
Day 10	85	17.70	12.7	29.6	1.11	N/A
Day 14	104	N/A	N/A	N/A	N/A	216

Hb: Hemoglobin (normal concentration: 110-150 g/L); TT: Thrombin time (normal: 14-21 s); PT: Prothrombin time (normal: 9.8-12.7 s); APTT: Activated partial thromboplastin time (normal: 21.1–36.5 s); INR: International normalized ratio (normal: 0.85-1.15); SCr: Serum creatinine (normal: 44-133 μmol/L); N/A: Not available.

Citation: Jia Y, Wang SH, Cui NJ, Liu QX, Wang W, Li X, Gu YM, Zhu Y. Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report. World J Clin Cases 2022; 10(8): 2537-2542
URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2537.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2537